Korean Chinese Japanese
  • Economy
  • Politics
  • Society
  • Securities
  • Real estate
  • Culture
  • Entertainment
  • Sports
  • Opinion
Korean Chinese Japanese
Economy Corporation Pharma & Bio
Society Politics IT·Science
Securities Real Estate Global
Opinion Entertainment Sports Culture
Video Auto in Golf in
PHARM EDAILY Market in TheBeLT
Securities
Stock Reports

"Target Price of 540,000 Won": SAMSUNG C&T CORPORATION Sees Positive Shareholder Returns Amid Strong Earnings

On the 25th, Heungkuk Securities announced that it is raising its target price for SAMSUNG C&T CORPORATION(028260)from 450,000 won to 540,000 won, citing expectations of solid third-quarter earnings. …
  • 2026-08-25 07:58:57
  • kyoungeun kim
Stock Reports

“LG H&H Sells U.S. Avon Business… A Positive Decision for the Stock Price”—LS

On the 25th, LS SECURITIES predicted that the sale of Avon’s North American business by LG H&H(051900)would have a positive impact on the company’s stock price. The firm maintained its “Buy” rating an…
  • 2026-08-25 07:55:59
  • Kim Kyung-eun
Stock Reports

HanmiPharm Transfers Technology to GenenTech for the First Time in Three Months… Target Price Raised to 730,000 Won ↑—Kiwoom

KIWOOM Securities assessed that HanmiPharm(128940)has once again demonstrated its research and development (R&D) competitiveness by licensing HM17321, a non-incretin-class obesity treatment candidate,…
  • 2026-08-25 07:53:08
  • KIM YOON-JEONG
Stock Reports

SamaAluminium: ESS Orders for North American Data Centers Are Key Growth Driver—Hana

Hana Securities forecast on the 25th that SamaAluminium(006110)will post its best-ever earnings next year since the company’s founding. However, it did not provide an investment recommendation or a ta…
  • 2026-08-25 07:51:27
  • Kwon Oh Seok
Stock Reports

HanmiPharm Signs 3.2 Trillion Won Technology Transfer Deal with Genentech for New Obesity Drug… Target Price Raised to 760,000 Won—NH

NH INVESTMENT & SECURITIES forecast that the value of HanmiPharm(128940)’s novel obesity treatment (LA-UCN2) will increase following a large-scale technology transfer agreement for a new obesity drug …
  • 2026-08-25 07:51:02
  • Kim Hyung-il
Stock Reports

JUNJIN C&R Anticipates Global Infrastructure and Reconstruction Demand—Yujin Robot Co., Ltd.

EUGENE INVESTMENT & SECURITIES maintained its “Buy” rating on #JUNJIN C&R on the 24th, noting that revenue growth is expected to turn around and profitability is expected to improve starting in the th…
  • 2026-08-24 08:06:40
  • Park Jung-Soo
Stock Reports

Samsung Life Insurance Expected to Benefit from SamsungElectronics’ Shareholder Returns… Whether Dividends Will Be Increased Remains to Be Seen—Hanwha

HANWHA INVESTMENT & SECURITIES assessed that while dividend income for Samsung Life Insurance(032830)is expected to increase following SamsungElectronics(005930)’s expansion of shareholder returns, it…
  • 2026-08-24 08:04:26
  • Kim Hyung-il
Stock Reports

SamsungElectronics’ Shareholder Returns to Benefit Preferred Shareholders… SAMSUNG C&T CORPORATION Dividends to Triple

SamsungElectronics(005930)has unveiled a shareholder return plan worth up to 110 trillion won, leading to analysis that SamsungElectronics preferred shares and SAMSUNG C&T CORPORATION(028260)could ben…
  • 2026-08-24 08:02:37
  • Kim Kyung-eun
Stock Reports

"It's heading toward 110,000 won"... Target price set at 70,000 won following Kakao's spin-off announcement

Kakao(035720) On the 24th, KIWOOM Securities stated that it had conservatively factored in the synergistic effects resulting from the spin-off of the artificial intelligence (AI) business and the inte…
  • 2026-08-24 08:00:06
  • Park Jung-Soo
Stock Reports

"Heading Toward 1.83 Million Won": Hanwha Aero’s K9MH Breaks Into the U.S. Market

DS Investment & Securities stated that the entry of HANWHA AEROSPACE(012450)’s K9 self-propelled howitzer into the U.S. market signifies more than just a single order. The firm raised its target price…
  • 2026-08-24 07:59:12
  • PARK MIN
prev 31 32 33 34 35 36 37 38 39 40 next

PHARM EDAILY

Shorts

EDAILY
  • 92, Tongil-ro, Jung-gu, Seoul, Korea
  • +82 2 3772 0114
  • webmaster@edaily.co.kr

※ This article has been translated using AI technology for the convenience of readers.

EDAILY provides this translation on an “as is” basis and makes no warranties, express or implied, regarding its accuracy, reliability, completeness, merchantability, or fitness for a particular purpose.
Due to the limitations of machine translation, the translated content may differ from the original Korean article. In the event of any discrepancy, the original Korean version shall prevail.
EDAILY shall not be liable for any loss or damage arising from the use of, or reliance on, the translated content.

© 2026 Copyrights by edaily. All Rights Reserved.
Korea China Japan
English